A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Phase 1/2 Recruiting
182 enrolled
TroFuse-022
Phase 3 Recruiting
770 enrolled
Prevention and Treatment of CINV Caused by TC Regimen in Gynecological Malignant Tumor Patients
Phase 3 Completed
143 enrolled
Folate Receptor in Diagnosing Ovarian Cancer Using Serum Samples From Patients With Newly Diagnosed Pelvic Mass or Previously Diagnosed Ovarian Cancer
Phase 1 Completed
50 enrolled
A Study Comparing the Combination of Trabectedin (YONDELIS) and DOXIL/CAELYX With DOXIL/CAELYX for the Treatment of Advanced-Relapsed Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Phase 3 Completed
581 enrolled 14 charts
Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer
Phase NA Terminated
4 enrolled 5 charts
Phase 1b/2 Study of Carfilzomib in Relapsed Solid Tumors, Multiple Myeloma, or Lymphoma
Phase 1/2 Completed
184 enrolled 36 charts
Tumor Gene Expression in Women With Ovarian Cancer
Phase 4 Completed
20 enrolled 5 charts
Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell Transplant
Phase NA Completed
40 enrolled 9 charts
An Efficacy and Safety Study for Yondelis (Trabectedin) in Patients With Advanced Relapsed Ovarian Cancer
Phase 3 Completed
672 enrolled 14 charts
Combination Chemotherapy in Treating Patients With Platinum-Resistant Recurrent Ovarian Cancer
Phase 2 Completed
35 enrolled